Skip to main navigationSkip to main content
The University of Southampton
Clinical Ethics and Law at Southampton

"Rapid technological advances promise big improvements in medical care. The world needs leadership in understanding and responding to the ethical and societal impact of these radical changes. CELS brings together interdisciplinary expertise to meet this need by addressing the ethical, legal and societal issues through research, education, policy engagement and public dialogue".

CELS Response to COVID-19 pandemic

The CELS team has recently redirected some of its ongoing research to COVID-19 (Coronavirus disease 2019) related work. We are interested in the ethical issues that were anticipated at the start of the pandemic – how these were debated and responded to by, for example, professional guidance and academic discourse, but also in the longer-term consequences of the pandemic on society

COVID-19 and ‘Big Qual’ - Dr Susie Weller

This post is written by Prof Lynn Jamieson along with Dr Emma Davidson (University of Edinburgh) and Prof Rosalind Edwards and Dr Susie Weller (University of Southampton). The blog discusses the potential of qualitative secondary analysis, and in particular ‘big qual’ analysis, for helping to overcome the restrictions placed on qualitative work during the global pandemic. In so doing, Lynn and colleagues draw on a recent ESRC National Centre for Research Methods study – Working across qualitative longitudinal studies: A feasibility study looking at care and intimacy.

Engaging with parents of the future about the offer of genetic screening before pregnancy

Lisa Ballard and her co-authors hope their findings about the consent process for genomic testing will inform the new NHS Genomic Medicine Service. The consent process for genomic testing is complex and involves communicating multiple considerations. Lisa tells us more about her recent research into the experience of patients who took part in the 100,000 Genomes Project, and what we can learn from them

GEP fellow, Dr Lisa Ballard, publishes research on patient experience

Lisa Ballard and her co-authors hope their findings about the consent process for genomic testing will inform the new NHS Genomic Medicine Service. The consent process for genomic testing is complex and involves communicating multiple considerations. Lisa tells us more about her recent research into the experience of patients who took part in the 100,000 Genomes Project, and what we can learn from them

CELS publishes educational article on direct-to-consumer genetic testing

Recently, members of CELS wrote an article about direct-to-consumer genetic testing that was published in the BMJ. The article discussed concerns that people buying direct-to-consumer tests might be falsely reassured by ‘negative’ results, and the issue that people who download and look at raw data from direct-to-consumer genetic tests might get worrying false positive results. This BMJ article was discussed in the national news, with Anneke Lucassen being quoted by the BBC News website, the Guardian, SkyNews and the Daily Mail online. The article was also cited in the recent position statement on direct-to-consumer genomic testing by the Royal College of GPs and the British Society for Genetic Medicine.

Tafida Raqeeb Judgment Summary: Continuation of Life-Sustaining Treatment in Italy held to be in Child’s Best Interests

This week, Mr Justice MacDonald handed down his judgment in the High Court, holding that continuation of medical treatment was in Tafida Raqeeb’s best interests. The effect of this decision being that she can be treated in Italy, in line with the wishes of her parents. This is a post from Transparency Project member, Emma Nottingham & Peta Coulson-Smith (Paeds Registrar, and Clinical Training Fellow & Senior Teaching Fellow in Clinical Ethics and Law at the University of Southampton)...

Privacy Settings